Cargando…
Targeted gene knockdown validates the essential role of lactate dehydrogenase in Cryptosporidium parvum
Cryptosporidium parvum is a zoonotic protozoan that can cause a life-threatening gastrointestinal syndrome in children and in immunocompromised adults. Currently, the only approved drug for treatment of Cryptosporidium infections in humans is nitazoxanide, but it is not effective in immunocompromise...
Autores principales: | Witola, William H., Zhang, Xuejin, Kim, Chi Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665856/ https://www.ncbi.nlm.nih.gov/pubmed/28606696 http://dx.doi.org/10.1016/j.ijpara.2017.05.002 |
Ejemplares similares
-
Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum
por: Li, Kun, et al.
Publicado: (2019) -
Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity
por: Zhang, Xuejin, et al.
Publicado: (2018) -
Cryptosporidium parvum Pyruvate Kinase Inhibitors With in vivo Anti-cryptosporidial Efficacy
por: Khan, Shahbaz M., et al.
Publicado: (2022) -
The effect of halofuginone lactate on experimental Cryptosporidium parvum infections in calves
por: Naciri, Muriel, et al.
Publicado: (1993) -
The Cryptosporidium parvum Kinome
por: Artz, Jennifer D, et al.
Publicado: (2011)